MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA safety review of medicines containing pseudoephedrine

Pseudoephedrine is used for the symptomatic relief of coughs, colds and allergies. Pseudoephedrine has been used in the UK for decades in millions and...

International – ICH releases draft guideline proposing harmonized bioequivalence testing

The International Council for Harmonisation (ICH) last month released a draft M13A guideline which proposes harmonized bioequivalence (BE) testing of new orally administered immediate-release...

International – ICH adopts Q13 guideline on continuous manufacturing

The International Council for Harmonisation (ICH) has adopted its guideline on continuous manufacturing (CM), in a nod to embracing more modern modes of manufacturing....

USA – FDA officials offer CMC advice for gene therapies at OTP town hall

Officials from the US Food and Drug Administration’s (FDA) Office of Therapeutic Products (OTP) within the Center for Biologics Evaluation and Research (CBER) urged...

Europe – European Health Union: Commission proposes pharmaceuticals reform for more accessible, affordable and...

Today, the Commission is proposing to revise the EU's pharmaceutical legislation - the largest reform in over 20 years - to make it more agile, flexible,...

USA – Accelerated approval trials: Commenters seek details on single-arm considerations

The US Food and Drug Administration (FDA) aimed to address some of the criticisms of its accelerated approval program with new draft guidance that...

Europe – Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)...

Seven new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its December 2023 meeting. The committee recommended granting a conditional...

Europe – CHMP recommends 12 new medicines, including first RSV treatment for infants

The European Medicine Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) last week endorsed 12 new medicines for authorization, including the first treatment to...
Epidemiological Evidence on the Adverse Health Effects Reported in Relation to Mercury from Dental Amalgam

USA – FDA relaxes EUA advertising limitation for some COVID drugs

The US Food and Drug Administration (FDA) has relaxed a limitation on advertising and promotion for certain COVID-19 drugs with emergency use authorizations (EUAs)....

USA – Generic manufacturers call for changes to list of major deficiencies

Generic drug manufacturers are urging the US Food and Drug Administration (FDA) to revise its guidance on amendments to Abbreviated New Drug Applications (ANDA)...